跳至主要内容
临床试验/DRKS00022238
DRKS00022238已完成未知

Individualized consideration of circadian rhythms to prevent sudden cardiac death - inZHerz

Otto-von-Guericke Universität Magdeburg, Medizinsiche Fakultät0 个研究点目标入组 23 人开始时间: 2020年7月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with indication for implantation of an ICD / CRT-D according to guidelines,
  • Patients with sinus rhythm or patients with paroxysmal atrial fibrillation,
  • Suitability for follow-up visits,
  • First implantation without a previous ICD / CRT-D system,
  • Patient is able to use CardioMessenger® including Home Monitoring®,
  • Signed declaration of consent.

排除标准

  • Patients with permanent atrial fibrillation,
  • Brugada syndrome,
  • Long and short QT syndrome,
  • COPD stages according to GOLD 3 to 4,
  • Life expectancy less than 6 months,
  • Patients who need permanent atrial stimulation
  • Age <18 years,
  • At the same time participants in another clinical trial,
  • Pregnancy or breastfeeding,
  • State according to HTX,
  • Chronic renal failure patients with stage 4 and 5,
  • Patients with active tumor diseases under chemotherapy / radiation therapy,
  • Therapy with local corticosteroid therapy.

研究者

发起方
Otto-von-Guericke Universität Magdeburg, Medizinsiche Fakultät

相似试验